Evolva initiates multiple ascending dose study with EV-077
 |  |  |
16.12.2010
Evolva SA announced that it has initiated a multiple ascending dose Phase I clinical study with an extended release oral formulation of
EV-077.
 | 62 kB |
| | |
16.12.2010
Evolva SA announced that it has initiated a multiple ascending dose Phase I clinical study with an extended release oral formulation of
EV-077.
| 62 kB |